Literature DB >> 3305321

Specificity of a mouse monoclonal antibody raised against acute myeloid leukaemia cells for mast cells in human mucosal and connective tissues.

G Mayrhofer, S J Gadd, L D Spargo, L K Ashman.   

Abstract

A mouse monoclonal antibody raised against acute myeloid leukaemia cells (YB5.B8 monoclonal antibody; Gadd, S. J. and Ashman, L. K. (1985): Leukaemia Res. 9, 1329-1336) has been found by an indirect immunoperoxidase technique to bind to scattered cells in frozen sections from a number of human tissues. They have been identified as mast cells in fixed sections of skin, tonsil and duodenum by simultaneous staining of glycosaminoglycan with Alcian blue in 0.7 N HCl. The antibody does not distinguish mast cells in mucosal tissues from those in connective tissue, although the level of expression by cells at both sites appears to be heterogeneous. With the exception of low affinity binding to B lymphocytes, no other bone marrow-derived cells were found to bind the antibody. In particular, basophils and eosinophils were not stained, suggesting that they are not related closely to mast cells and that the antigen detected by YB5.B8 monoclonal antibody is not an IgE Fc receptor. Therefore, among all mature haemopoietic lineages, the antibody is specific for mast cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305321     DOI: 10.1038/icb.1987.27

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  12 in total

Review 1.  Urticaria pigmentosa and mastocytosis: the role of immunophenotyping in diagnosis and determining response to treatment.

Authors:  Cem Akin; Peter Valent; Luis Escribano
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

2.  Differential expression of cell surface integrins on human mast cells and human basophils.

Authors:  W R Sperr; H Agis; K Czerwenka; W Klepetko; E Kubista; G Boltz-Nitulescu; K Lechner; P Valent
Journal:  Ann Hematol       Date:  1992-07       Impact factor: 3.673

3.  Absence of immature mast cells in the skin of Ws/Ws rats with a small deletion at tyrosine kinase domain of the c-kit gene.

Authors:  H Onoue; K Maeyama; S Nomura; T Kasugai; H Tei; H M Kim; T Watanabe; Y Kitamura
Journal:  Am J Pathol       Date:  1993-04       Impact factor: 4.307

4.  Interleukin 3 activates human blood basophils via high-affinity binding sites.

Authors:  P Valent; J Besemer; M Muhm; O Majdic; K Lechner; P Bettelheim
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

5.  Phenotypic characterization of stem cell factor-dependent human foetal liver-derived mast cells.

Authors:  G Nilsson; K Forsberg; M P Bodger; L K Ashman; K M Zsebo; T Ishizaka; A M Irani; L B Schwartz
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

6.  Expression of a B-cell-restricted isoform of CD45 is associated with maturity in rat serosal and connective-tissue mast cells.

Authors:  Chunping Yu; Mahin Moghaddami; Graham Mayrhofer
Journal:  Immunology       Date:  2008-12       Impact factor: 7.397

7.  Human mast cells produce type VIII collagen in vivo.

Authors:  B Rüger; P R Dunbar; Q Hasan; H Sawada; R Kittelberger; N Greenhill; T J Neale
Journal:  Int J Exp Pathol       Date:  1994-12       Impact factor: 1.925

8.  Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor.

Authors:  A A Irani; G Nilsson; L K Ashman; L B Schwartz
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

9.  Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand.

Authors:  H Mitsui; T Furitsu; A M Dvorak; A M Irani; L B Schwartz; N Inagaki; M Takei; K Ishizaka; K M Zsebo; S Gillis
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

10.  c-kit ligand: a unique potentiator of mediator release by human lung mast cells.

Authors:  S C Bischoff; C A Dahinden
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.